D-SPECT BIS
Study of the Concordance Between a Traditional Protocol of Stress and Rest Myocardial Tomoscintigraphy Using 99mTc-sestamibi and a Double Isotope Protocol Using Thallium-201 and 99mTc-sestamibi, With a Semiconductor Camera
Sponsor study identifier
interventional
118
1 country
2
Study Start
September 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2015
Actual (reported)Study Completion
November 2015
Actual (reported)The purpose is to demonstrate the concordance of diagnostic information obtained with:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2012
Date type not reportedThis date has not been verified as actual or estimated.
November 2015
Actual (reported)November 2015
Actual (reported)August 9, 2016
Actual (reported)August 16, 2016
Actual (reported)Quality of images obtained with double isotope tomoscintigraphy and conventional tomoscintigraphy
Bad; medium; good; very good
day 0
Nature of observed abnormalities obtained with double isotope tomoscintigraphy and conventional tomoscintigraphy
Without abnormalities or artefacts (normal); with rest reversible abnormalities (ischemia); with rest non reversible abnormalities (infarction)
day 0
Patients with abnormalities of myocardial perfusion detected with stress tomoscintigraphy, undergo double isotope myocardial tomoscintigraphy using Thallium-201 and 99mTc-sestamibi and traditional myocardial tomoscintigraphy using 99mTc-sestamibi with a semiconductor camera
* During stress test, intravenous injection of 99mTc-Sestamibi (between 80 and 150 MBq according to weight) in patient * Stress conventional acquisition with D.SPECT camera 20 min after injection * 60 min after 99mTc-Sestamibi injection, rest injection of thallium-201 (50% activity of stress 99mTc-Sestamibi) * double isotope acquisition 5 min after thallium-201 injection * injection of 99mTc-Sestamibi at rest (activity 3 times higher), after 2 hours from first 99mTc-Sestamibi injection * rest conventional acquisition 20 min later
Service de Médecine Nucléaire - CLCC Jean Perrin
Clermont-Ferrand, France
Service de Médecine Nucléaire - Hôpital de Brabois
Vandœuvre-lès-Nancy, France
Wassila DJABALLAH, Dr
Service de Médecine Nucléaire, Hôpital de Brabois, 54511 Vandœuvre les Nancy
118 participants (actual enrollment reported by the registry).
First Submitted
August 9, 2016
First Posted
August 16, 2016
Study Start
September 2012
Date type not reportedThis date has not been verified as actual or estimated.
The CZT Dynamic Myocardial Perfusion Imaging
First intravenous injection between 80 and 150 MBq according to patient weight and second injection with 3-time-higher activity, 2 hours after the first For tomoscintigraphy
Injection of thallium-201 (50% activity of first 99mTc-Sestamibi injection) For tomoscintigraphy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
November 2015
Actual (reported)Study Completion
November 2015
Actual (reported)Last Updated
August 16, 2016
Record last verified: 2016-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: